June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Evaluation of chronic effects of e-cigarette aerosol inhalation on macular perfusion using OCT-Angiography
Author Affiliations & Notes
  • Arathi Ponugoti
    Duke University School of Medicine, Durham, North Carolina, United States
  • Hoan Ngo
    Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Viet Nam
  • Sandra S. Stinnett
    Duke University Department of Ophthalmology, Durham, North Carolina, United States
  • Lejla Vajzovic
    Duke University Department of Ophthalmology, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   Arathi Ponugoti, None; Hoan Ngo, None; Sandra Stinnett, None; Lejla Vajzovic, Heidelberg Engineering (F)
  • Footnotes
    Support  VitreoRetinal Surgery Foundation Research Award
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 2471. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Arathi Ponugoti, Hoan Ngo, Sandra S. Stinnett, Lejla Vajzovic; Evaluation of chronic effects of e-cigarette aerosol inhalation on macular perfusion using OCT-Angiography. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2471.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Electronic cigarette (e-cig) use in young adults has increased dramatically, the long-term effects of which are largely unknown. Acute impaired microvascular function and endothelial vascular dysfunction have been observed during e-cig use but chronic vascular effects of use remain underexplored, especially in the delicate and highly metabolically active retina where such effects might present earlier. We performed a cross sectional clinical observational study to determine if there are differences at baseline in the microvasculature and central retinal thickness (CRT) between e-cig users and age matched non-user controls using OCTA.

Methods : We obtained 10x10 scan angle images of right and left maculae in 26 adult daily e-cig users and right eye maculae in 25 age matched controls using an OCTA integrated Spectralis SD-OCT tabletop system (Heidelberg Engineering, Germany). A customized MATLAB algorithm was used to calculate foveal avascular zone (FAZ), vessel area density (VAD), and vessel length density (VLD) for the superficial and deep vascular complexes (SVC and DVC). Spectralis software was used to calculate foveal, superior, inferior, nasal, and temporal CRT. Wilcoxon rank sum tests were used to assess variability of FAZ, VAD, VLD, and CRT parameters between groups and differential contribution of e-liquid concentration and years of e-sig use.

Results : Images were acquired in 52 e-cig user eyes (n= 26, mean age 27.8 ± 6.72yrs) and 25 non-user age matched controls (n=25, mean age 28.04 ± 4.53yrs). FAZ, VAD, VLD, and CRT were measured in all 77 eyes. No statistically significant difference was found between users and non-users for FAZ, SVC VAD, SVC VLD, or DVC VAD. A statistically significant difference was found for DVC VLD (p=.0003), with e-cig users having a slightly higher VLD on average. Inferior CRT was significantly thinner in users compared to non-users (p=.012). E-liquid concentration significantly correlated with thinner inferior CRT in e-cig users (Pr>F .0408).

Conclusions : Overall, no significant negative differences were found in the retinal microvasculature parameters between e-cig users and non-users. Decreased inferior CRT in e-cig users might not be clinically meaningful at this time but warrants further assessment of retinal effects as this population ages and continues to use e-cigs.

This is a 2021 ARVO Annual Meeting abstract.

 

Fig 1. SVC and DVC in e-cigarette user (1A, 1B) and age-matched control (1C, 1D).

Fig 1. SVC and DVC in e-cigarette user (1A, 1B) and age-matched control (1C, 1D).

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×